Guidance for considering ethical, legal, and social issues in health technology assessment

application to genetic screening

Beth K Potter, Denise Avard, Ian D Graham, Vikki A Entwistle, Timothy A Caulfield, Pranesh Chakraborty, Christine Kennedy, Marissa McGuire, Glenn G Griener, Mark Montgomery, George A Wells, Brenda J Wilson

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

OBJECTIVES AND METHODS: Many authors have argued that ethical, legal, and social issues ("ELSIs") should be explicitly integrated into health technology assessment (HTA), yet doing so poses challenges. This discussion may be particularly salient for technologies viewed as ethically complex, such as genetic screening. Here we provide a brief overview of contemporary discussions of the issues from the HTA literature. We then describe key existing policy evaluation frameworks in the fields of disease screening and public health genomics. Finally, we map the insights from the HTA literature to the policy evaluation frameworks, with discussion of the implications for HTA in genetic screening. RESULTS AND CONCLUSIONS: A critical discussion in the HTA literature considers the definition of ELSIs in HTA, highlighting the importance of thinking beyond ELSIs as impacts of technology. Existing HTA guidance on integrating ELSIs relates to three broad approaches: literature synthesis, involvement of experts, and consideration of stakeholder values. The thirteen key policy evaluation frameworks relating to disease screening and public health genomics identified a range of ELSIs relevant to genetic screening. Beyond straightforward impacts of screening, these ELSIs require consideration of factors such as the social and political context surrounding policy decisions. The three broad approaches to addressing ELSIs described above are apparent in the screening/genomics literatures. In integrating these findings we suggest that the method chosen for addressing ELSIs in HTA for genetic screening may determine which ELSIs are prioritized; and that an important challenge is the lack of guidance for evaluating such methods.
Original languageEnglish
Pages (from-to)412-422
Number of pages11
JournalInternational Journal of Technology Assessment in Health Care
Volume24
Issue number4
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Biomedical Technology Assessment
Genetic Testing
Genomics
Public Health
Technology

Keywords

  • genetic screening
  • ethical
  • legal
  • and social issues
  • health technology assessment

Cite this

Guidance for considering ethical, legal, and social issues in health technology assessment : application to genetic screening. / Potter, Beth K; Avard, Denise; Graham, Ian D; Entwistle, Vikki A; Caulfield, Timothy A; Chakraborty, Pranesh; Kennedy, Christine; McGuire, Marissa; Griener, Glenn G; Montgomery, Mark; Wells, George A; Wilson, Brenda J.

In: International Journal of Technology Assessment in Health Care, Vol. 24, No. 4, 10.2008, p. 412-422.

Research output: Contribution to journalArticle

Potter, BK, Avard, D, Graham, ID, Entwistle, VA, Caulfield, TA, Chakraborty, P, Kennedy, C, McGuire, M, Griener, GG, Montgomery, M, Wells, GA & Wilson, BJ 2008, 'Guidance for considering ethical, legal, and social issues in health technology assessment: application to genetic screening', International Journal of Technology Assessment in Health Care, vol. 24, no. 4, pp. 412-422. https://doi.org/10.1017/S0266462308080549
Potter, Beth K ; Avard, Denise ; Graham, Ian D ; Entwistle, Vikki A ; Caulfield, Timothy A ; Chakraborty, Pranesh ; Kennedy, Christine ; McGuire, Marissa ; Griener, Glenn G ; Montgomery, Mark ; Wells, George A ; Wilson, Brenda J. / Guidance for considering ethical, legal, and social issues in health technology assessment : application to genetic screening. In: International Journal of Technology Assessment in Health Care. 2008 ; Vol. 24, No. 4. pp. 412-422.
@article{caced2d8d6ea4e549020fbecbe84cc24,
title = "Guidance for considering ethical, legal, and social issues in health technology assessment: application to genetic screening",
abstract = "OBJECTIVES AND METHODS: Many authors have argued that ethical, legal, and social issues ({"}ELSIs{"}) should be explicitly integrated into health technology assessment (HTA), yet doing so poses challenges. This discussion may be particularly salient for technologies viewed as ethically complex, such as genetic screening. Here we provide a brief overview of contemporary discussions of the issues from the HTA literature. We then describe key existing policy evaluation frameworks in the fields of disease screening and public health genomics. Finally, we map the insights from the HTA literature to the policy evaluation frameworks, with discussion of the implications for HTA in genetic screening. RESULTS AND CONCLUSIONS: A critical discussion in the HTA literature considers the definition of ELSIs in HTA, highlighting the importance of thinking beyond ELSIs as impacts of technology. Existing HTA guidance on integrating ELSIs relates to three broad approaches: literature synthesis, involvement of experts, and consideration of stakeholder values. The thirteen key policy evaluation frameworks relating to disease screening and public health genomics identified a range of ELSIs relevant to genetic screening. Beyond straightforward impacts of screening, these ELSIs require consideration of factors such as the social and political context surrounding policy decisions. The three broad approaches to addressing ELSIs described above are apparent in the screening/genomics literatures. In integrating these findings we suggest that the method chosen for addressing ELSIs in HTA for genetic screening may determine which ELSIs are prioritized; and that an important challenge is the lack of guidance for evaluating such methods.",
keywords = "genetic screening, ethical , legal, and social issues, health technology assessment",
author = "Potter, {Beth K} and Denise Avard and Graham, {Ian D} and Entwistle, {Vikki A} and Caulfield, {Timothy A} and Pranesh Chakraborty and Christine Kennedy and Marissa McGuire and Griener, {Glenn G} and Mark Montgomery and Wells, {George A} and Wilson, {Brenda J}",
year = "2008",
month = "10",
doi = "10.1017/S0266462308080549",
language = "English",
volume = "24",
pages = "412--422",
journal = "International Journal of Technology Assessment in Health Care",
issn = "0266-4623",
publisher = "Cambridge University Press",
number = "4",

}

TY - JOUR

T1 - Guidance for considering ethical, legal, and social issues in health technology assessment

T2 - application to genetic screening

AU - Potter, Beth K

AU - Avard, Denise

AU - Graham, Ian D

AU - Entwistle, Vikki A

AU - Caulfield, Timothy A

AU - Chakraborty, Pranesh

AU - Kennedy, Christine

AU - McGuire, Marissa

AU - Griener, Glenn G

AU - Montgomery, Mark

AU - Wells, George A

AU - Wilson, Brenda J

PY - 2008/10

Y1 - 2008/10

N2 - OBJECTIVES AND METHODS: Many authors have argued that ethical, legal, and social issues ("ELSIs") should be explicitly integrated into health technology assessment (HTA), yet doing so poses challenges. This discussion may be particularly salient for technologies viewed as ethically complex, such as genetic screening. Here we provide a brief overview of contemporary discussions of the issues from the HTA literature. We then describe key existing policy evaluation frameworks in the fields of disease screening and public health genomics. Finally, we map the insights from the HTA literature to the policy evaluation frameworks, with discussion of the implications for HTA in genetic screening. RESULTS AND CONCLUSIONS: A critical discussion in the HTA literature considers the definition of ELSIs in HTA, highlighting the importance of thinking beyond ELSIs as impacts of technology. Existing HTA guidance on integrating ELSIs relates to three broad approaches: literature synthesis, involvement of experts, and consideration of stakeholder values. The thirteen key policy evaluation frameworks relating to disease screening and public health genomics identified a range of ELSIs relevant to genetic screening. Beyond straightforward impacts of screening, these ELSIs require consideration of factors such as the social and political context surrounding policy decisions. The three broad approaches to addressing ELSIs described above are apparent in the screening/genomics literatures. In integrating these findings we suggest that the method chosen for addressing ELSIs in HTA for genetic screening may determine which ELSIs are prioritized; and that an important challenge is the lack of guidance for evaluating such methods.

AB - OBJECTIVES AND METHODS: Many authors have argued that ethical, legal, and social issues ("ELSIs") should be explicitly integrated into health technology assessment (HTA), yet doing so poses challenges. This discussion may be particularly salient for technologies viewed as ethically complex, such as genetic screening. Here we provide a brief overview of contemporary discussions of the issues from the HTA literature. We then describe key existing policy evaluation frameworks in the fields of disease screening and public health genomics. Finally, we map the insights from the HTA literature to the policy evaluation frameworks, with discussion of the implications for HTA in genetic screening. RESULTS AND CONCLUSIONS: A critical discussion in the HTA literature considers the definition of ELSIs in HTA, highlighting the importance of thinking beyond ELSIs as impacts of technology. Existing HTA guidance on integrating ELSIs relates to three broad approaches: literature synthesis, involvement of experts, and consideration of stakeholder values. The thirteen key policy evaluation frameworks relating to disease screening and public health genomics identified a range of ELSIs relevant to genetic screening. Beyond straightforward impacts of screening, these ELSIs require consideration of factors such as the social and political context surrounding policy decisions. The three broad approaches to addressing ELSIs described above are apparent in the screening/genomics literatures. In integrating these findings we suggest that the method chosen for addressing ELSIs in HTA for genetic screening may determine which ELSIs are prioritized; and that an important challenge is the lack of guidance for evaluating such methods.

KW - genetic screening

KW - ethical

KW - legal

KW - and social issues

KW - health technology assessment

U2 - 10.1017/S0266462308080549

DO - 10.1017/S0266462308080549

M3 - Article

VL - 24

SP - 412

EP - 422

JO - International Journal of Technology Assessment in Health Care

JF - International Journal of Technology Assessment in Health Care

SN - 0266-4623

IS - 4

ER -